Segment Information (Total assets by reportable segment) (Details) - USD ($) $ in Thousands |
Jun. 30, 2021 |
Dec. 31, 2020 |
|---|---|---|
| Segment Reporting Information [Line Items] | ||
| Intangible asset, net | $ 13,701 | $ 14,629 |
| Tangible assets | 404,457 | 318,784 |
| Total assets | 418,158 | 333,413 |
| Dermatology Products Sales [Member] | ||
| Segment Reporting Information [Line Items] | ||
| Intangible asset, net | 13,701 | 14,629 |
| Tangible assets | 53,712 | 35,422 |
| Total assets | 67,413 | 50,051 |
| Pharmaceutical and Biotechnology Product Development [Member] | ||
| Segment Reporting Information [Line Items] | ||
| Intangible asset, net | 0 | 0 |
| Tangible assets | 350,745 | 283,362 |
| Total assets | $ 350,745 | $ 283,362 |
| X | ||||||||||
- Definition Tangible assets. No definition available.
|
| X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|